Reset
Page 1 of 1 Pages
Posts Per Page
Jordan Smith commented 3 weeks ago
#31292

 

Presently, in silico tools / approaches are available for the identification, selection and optimization of pharmacological leads. in fact, the predictive power of such solutions has been demonstrated to enable researchers to bypass the traditional experimental screening of billions of molecules against hundreds of biological targets, thereby, allowing significant reductions in the investment of both time and resources.

 

To order this 290+ page report, which features 120+ figures and 135+ tables, please visit this link

 

The USD 124 million (by 2030) financial opportunity within the in silico drug discovery market for large molecules has been analyzed across the following segments:

  • Key Drug Discovery Steps
  • Target Identification
  • Target Validation
  • Hit Generation
  • Hit-to-Lead
  • Lead Optimization 

 

  • Type of Large Molecule
  • Antibodies
  • Proteins
  • Peptides
  • Nucleic Acids
  • Vectors

 

  • Company Size
  • Small
  • Mid-sized
  • Large

 

  • Target therapeutic Area
  • Autoimmune Disorders
  • Blood Disorders
  • Cardiovascular Disorders
  • Gastrointestinal and Digestive Disorders
  • Hormonal Disorders
  • Human Immunodeficiency Virus (HIV) / Acquired Immunodeficiency Syndrome (AIDS)
  • Infectious Diseases
  • Metabolic Disorders
  • Mental Disorders
  • Musculoskeletal Disorders
  • Neurological Disorders
  • Oncological Disorders
  • Respiratory Disorders
  • Skin Disorders
  • Urogenital Disorders
  • Others

 

  • Type of Sponsor
  • Industry Players
  • Non-Industry Players

 

  • Key Geographical Regions
  • North America
  • Europe
  • Asia-Pacific

 

The In Silico / Computer-Aided Drug Discovery Services Market: Focus on Large Molecules, 2020-2030, report features the following companies, which we identified to be key players in this domain:

  • Abzena
  • BioDuro
  • BioNTech
  • ChemPartner
  • Creative Biostructure
  • GenScript
  • LakePharma
  • Sundia MediTech
  • Sygnature Discovery
  • Viva Biotech

 

Table of Contents

 

1. Preface

2. Executive Summary


3. Introduction
 

4. Market Landscape
 

5. Key Insights
 

6. Company Profiles
 

7. Company Competitiveness Analysis 
 

8. Key Opportunity Areas
 

9. Emerging Business Models and Strategies
 

10. Case study: comparison of drug discovery processes of small molecules     and large molecules
 

11. Survey insights
 

12. Cost saving analysis
 

13. Market Forecast
 

14. In silico tools and upcoming trends in drug discovery

 

15. Executive Insights

 

16. Appendix 1: Tabulated Data

 

17. Appendix 2: List of Companies and Organizations

 

18. Appendix 3: Non-Computational Methods for Drug Discovery

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/in-silico-drug-discovery/298.html

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com

 


Information!  Use the form below to reply to this forum thread or, to reply to an individual post, use the "Quote" button on the relevant post.